Press Releases

 

Please find below the latest news from Yourgene Health. We also share this news across social media networks.

Prev Next
17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

Yourgene’s LightBench instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields

Manchester, UK, 16 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimise size selection for long-read sequencing workflows. PacBio has qualified Yourgene’s LightBench® instrument for the size selection of long DNA fragments, enabling high yields for HiFi sequencing data.

read more
17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

9 November 2023 – Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents

Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Morocco based on the IONA® test at the Centre de Biologie Riad (Laboriad). By offering this service locally, Laboriad can broaden its offering and provide pregnant women fast, reliable results that reduce the need for invasive tests and the associated stress and anxiety for expectant parents.

read more
17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

7 November 2023 -IVDR certification achieved for DPYD genotyping assay – First product of its kind to conform with new IVDR requirements

IVDR certification achieved for DPYD genotyping assay

First product of its kind to conform with new IVDR requirements

Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy.

read more
17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

5 September 2023 – Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow

Manchester, UK, and SINGAPORE, 5 September 2023: Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit.

read more
17 November 2023 – Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

25 January 2023 – Directorate Change

Andy Leeser is one of the UK’s most experienced mid-market corporate transformation specialists. He has been involved with a range of transformation projects and transactions, including refinancings and equity/ asset sales across the Automotive, Oil and Gas, Brewing, Retail and Telecommunications sectors.

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

16 August 2022 – Open Day and advance notice of AGM

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Open Day and advance notice of AGM Manchester, UK – 16 August 2022: Yourgene (AIM: YGEN), the international molecular diagnostics group, will be hosting an Open Day at its new facilities on Manchester...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

27 July 2022 – Audited Final Results

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Audited Final Results    Manchester, UK – 27 July 2022: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces its final results for the financial year ended 31 March...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

27 July 2022 – Dr John Brown CBE confirmed as Chairman

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Dr John Brown CBE confirmed as Chairman Manchester, UK – 27 July 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, confirms the appointment of Dr John Brown CBE as Chairman...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

26 April 2022 – Full year trading update

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Full year trading update Manchester, UK – 26 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, provides the following unaudited trading update for the year ended 31...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

26 April 2022 – Directorate Change

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate Change Manchester, UK – 26 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that after a five-year tenure, Adam Reynolds will step down from...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

06 April 2022 – Capital Markets Day

Yourgene Health plc (“Yourgene”  or the “Company”) Capital Markets Day Manchester, UK – 6 April 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it will be holding a Capital Markets Day for investors on Tuesday 26 April...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

17 February 2022 – Successful CTDA desktop review

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Successful CTDA desktop review Approval for sale of Clarigene® SARS-CoV-2 Test in the UK Manchester, UK - 17 February 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostic group,...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

25 January 2022 – Directorate Change

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate Change Manchester, UK - 25 January 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces the appointment of Mary Tavener as a Non-executive Director...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

19 January 2022 – Agreement of new debt facility

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Agreement of new debt facility Silicon Valley Bank facility to provide non-dilutive funding for accretive growth opportunities Manchester, UK – 19 January 2022: Yourgene (AIM: YGEN), a leading...

read more
25 Aug 2022 – Notice of AGM, Change of Registered Address and Investor Presentation

17 January 2022 – Current year trading update

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Current year trading update Further upgrade to full year revenue guidance following strong trading performance Manchester, UK – 17 January 2022: Yourgene (AIM: YGEN), the international molecular...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

14 December 2021 – Half-year Report

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) H1 revenues doubled year-on-yearFull year revenues to exceed already upgraded market expectations Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading integrated technologies and service...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

14 December 2021 – UKHSA contract award

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) UKHSA contract awardContract for the provision of the genetic sequencing services Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

18 November 2021 – DPYD screening recommended in Spain

Yourgene Health plc(“Yourgene” or the “Company”) DPYD screening recommended in SpainFollows recommendations in Germany, Wales, England and Belgium Manchester, UK – 18 November 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, welcomes...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

26 October 2021 – Half-year Trading update

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateImproved H1 and year-to-date performance supporting higher full-year expectations Manchester, UK – 26 October 2021: Yourgene (AIM: YGEN), a leading international molecular...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

28 September 2021 – AGM Statement Investor presentation

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM StatementInvestor presentation Manchester, UK - 28 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, will be holding its Annual General Meeting (AGM)...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

1 September 2021 – Notice of AGM and Annual Report 2021

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Notice of AGM and Annual Report 2021Investor presentation Manchester, UK 1 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that the Notice of Annual...

read more
23 Dec 21 – DHSC contract awarded to support COVID-19 Winter surge testing

18 May 2021 – Launch of IONA® Care NIPT service offering

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of IONA® Care NIPT service offeringExtended clinical menu to screen SCAs and AAs for pregnant women Manchester, UK – 18 May 2021: Yourgene (AIM: YGEN), the international molecular diagnostics...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

17 December 2020 – Half-year Report

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Report Manchester, UK – 17 December 2020: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces its...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

2 December 2020 – DPYD kits recommended by NHS England

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPYD kits recommended by NHS England Manchester, UK – 2 December 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, welcomes the Clinical Commissioning Urgent Policy Statement,...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

5 November 2020 – Directorate change

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate changeChief Scientific Officer appointment to drive new product development roadmap Manchester, UK – 5 November 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group,...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

3 November 2020 – Partnership with Take2 Health Limited

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Partnership with Take2 Health LimitedYourgene to run genomic test for Nasopharyngeal Carcinoma (NPC) Screening in Taiwan Manchester, UK – 3 November 2020: Yourgene (AIM: YGEN), the international...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

26 October 2020 – Half-year Trading update

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateH1 year-on-year growth demonstrating the resilience of the Company Manchester, UK – 26 October 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group,...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

23 October 2020 – CQC registration

Yourgene Health plc(“Yourgene Health” or the "Company") CQC registration Manchester, UK – 23 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received notification from the Care Quality Commission...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

3 August 2020 – CE-IVD Mark for Clarigene™ SARS-CoV-2 test

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) CE-IVD Mark for Clarigene™ SARS-CoV-2 test Manchester, UK – 3 August 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has achieved CE-IVD marking for its...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

28 September 2020 – Launch of Yourgene Genomic Services

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of Yourgene Genomic Services Manchester, UK – 28 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of Yourgene Genomic Services, an...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

24 September 2020 – DPD reimbursement in Germany

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPD reimbursement in Germany Manchester, UK – 24 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that the German Federal Joint Committee, G-BA, the national...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

22 September 2020 – AGM statement

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM Statement Manchester, UK – 22 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, will be holding its Annual General Meeting (AGM) at 4:00pm today. At the meeting,...

read more
24 December 2020 – COVID-19 update: approved provider for UK Government and response to new virus strain

3 September 2020 – IONA® Nx Launch

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) IONA® Nx Launch Manchester, UK – 3 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of IONA® Nx NIPT workflow, the Company’s new innovative...

read more
2 December 2019 – Half-year Report

2 December 2019 – Half-year Report

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.  Yourgene Health plc  (“Yourgene”, the “Company” or the “Group”)  Half-year Report  Manchester, UK – 2 December 2019: Yourgene Health plc (AIM:...

read more
2 December 2019 – Half-year Report

29 November 2019 – Bionow Double Award Wins

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Bionow Double Award Wins Manchester, UK – 29 November 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has won Bionow Investment Deal of Year and Bionow...

read more
2 December 2019 – Half-year Report

14 October 2019 – Half year trading update

Yourgene Health plc (“Yourgene” or the “Group”) Half year trading update Manchester, UK – 14 October 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, provides a positive trading update for the six months to 30 September 2019....

read more
2 December 2019 – Half-year Report

26 September 2019 – CE-IVD Certification renewal

CE-IVD Certification renewal Manchester, UK – 26 September 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that in preparation for a 2020 product launch and as a contingency for BREXIT, the Company has successfully...

read more
2 December 2019 – Half-year Report

20 August 2019 – Notice of AGM 

Yourgene Health plc (“Yourgene” or the “Company”) Notice of AGM Manchester, UK – 20 August 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Annual General Meeting (AGM) will be held at 4:00pm on 17 September 2019 at...

read more
2 December 2019 – Half-year Report

29 July 2019 – Appointment of Director

Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Appointment of Director Manchester, UK – 29 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the...

read more
2 December 2019 – Half-year Report

25 April 2019 – Completion of Acquisition

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR PUBLIC RELEASE, PUBLICATION, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY...

read more
2 December 2019 – Half-year Report

8 April 2019 – Full-year Trading Update

Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Full-year Trading Update Manchester, UK – 8 April 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces a trading...

read more